Citation Impact
Citing Papers
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2008 Standout
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Interventions for treating depression after stroke
2008
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder
2002
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
Depression
2018 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Pharmacokinetics of selective serotonin reuptake inhibitors
2000
Aging and Clinical Pharmacology: Implications for Antidepressants
2005
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
Collaborative Care for Depression
2006 Standout
Pharmacology of antidepressants
2001
Epidemiology and treatment of post-stroke depression
2008
Paroxetine
1991
Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review
2003
Is dose escalation of antidepressants a rational strategy after a medium–dose treatment has failed?
2005
Depression in Late Life: Review and Commentary
2003 Standout
An Overview of Psychotropic Drug-Drug Interactions
2005
Metabolic Drug Interactions with Newer Antipsychotics: A Comparative Review
2006
Paroxetine: A Selective Serotonin Reuptake Inhibiting Antidepressant
1993
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials
2009
Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review
2016
Tripping on nothing: placebo psychedelics and contextual factors
2020 Standout
Paroxetine: A Review
2001
Herb-Drug Interactions
2005 Standout
Interactions between antiepileptics and second-generation antipsychotics
2012
Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome
2009
AGA technical review on irritable bowel syndrome
2002 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Impact of the Ultrarapid CYP2C19*17 Allele on Serum Concentration of Escitalopram in Psychiatric Patients
2007
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians
2008
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Pharmaceutical interventions for emotionalism after stroke
2010
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
2002
Palliative and End-of-Life Care in Stroke
2014
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012
2015 Standout
Selective Serotonin Reuptake Inhibitors for Stroke Recovery
2013
Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners
2003
Selective serotonin reuptake inhibitors in affective disorders — I. Basic pharmacology
1998
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
Gender differences in the pharmacokinetics and pharmacodynamics of antidepressants.
2003
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Variation in CYP1A2 Activity and its Clinical Implications: Influence of Environmental Factors and Genetic Polymorphisms
2008
Works of Jöns Lundmark being referenced
Therapeutic Drug Monitoring of Sertraline: Variability Factors as Displayed in a Clinical Setting
2000
Double-Blind Comparison of Sertraline and Placebo in Stroke Patients With Minor Depression and Less Severe Major Depression
2005
Serum Levels of Citalopram and Its Main Metabolites in Adolescent Patients Treated in a Naturalistic Clinical Setting
2002
Paroxetine: pharmacokinetic and antidepressant effect in the elderly
1989
Therapeutic Drug Monitoring Data on Olanzapine and Its N-Demethyl Metabolite in the Naturalistic Clinical Setting
2002
Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients
2000
Enantioselective Analysis of Citalopram and Metabolites in Adolescents
2001
A therapeutic drug monitoring (TDM) routine clearly improves dosing, postmarketing surveillance, and drug safety for SSRIs
1997
127 TDM OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS TREATING DEPRESSION IN THE ELDERLY REDUCES DRUG DOSES AND COSTS
1997